BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Travin MI, Feng D, Taub CC. Novel Imaging Approaches for Predicting Arrhythmic Risk. Circ Cardiovasc Imaging 2015;8:e003019. [PMID: 26565012 DOI: 10.1161/CIRCIMAGING.115.003019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Radu S, Floria M. Ventricular arrhythmic risk prediction: simpler is easier. Minerva Cardioangiol 2020;68:556-8. [PMID: 33059406 DOI: 10.23736/S0026-4725.20.05389-X] [Reference Citation Analysis]
2 Velasco A, Doppalapudi H. Noninvasive myocardial blood flow assessment: Another marker of arrhythmic risk? J Nucl Cardiol 2019;26:428-30. [DOI: 10.1007/s12350-017-0989-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Travin MI, Matsunari I, Thomas GS, Nakajima K, Yoshinaga K. How Do We Establish Cardiac Sympathetic Nervous System Imaging with <sup>123</sup>I-<I>m</I>IBG in Clinical Practice? Perspectives and Lessons from Japan and the US. Annals of Nuclear Cardiology 2019;5:5-20. [DOI: 10.17996/anc.18-003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Travin MI. Multimodality molecular imaging in predicting ventricular arrhythmias and sudden cardiac death. J Nucl Cardiol 2017;24:239-44. [DOI: 10.1007/s12350-016-0588-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Travin MI, Matsunari I, Thomas GS, Nakajima K, Yoshinaga K. How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? J Nucl Cardiol. 2019;26:1434-1451. [PMID: 30178272 DOI: 10.1007/s12350-018-1394-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Travin MI. Neurocardiac imaging has a proven value in patient management. J Nucl Cardiol 2017;24:1588-93. [PMID: 28593534 DOI: 10.1007/s12350-017-0948-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Wang YY, Mesirca P, Marqués-Sulé E, Zahradnikova A Jr, Villejoubert O, D'Ocon P, Ruiz C, Domingo D, Zorio E, Mangoni ME, Benitah JP, Gómez AM. RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism. JCI Insight 2017;2:91872. [PMID: 28422759 DOI: 10.1172/jci.insight.91872] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Kariki O, Antoniou CK, Mavrogeni S, Gatzoulis KA. Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist. Diagnostics (Basel) 2020;10:E541. [PMID: 32751773 DOI: 10.3390/diagnostics10080541] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
9 Travin MI. Assessing arrhythmic risk with 123I-mIBG and analogous tracers: Image interpretation from a different viewpoint. J Nucl Cardiol 2019;26:118-22. [DOI: 10.1007/s12350-017-0968-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]